In development: Guidance, quality standards and advice
Showing 1 to 2 of 2
| Title | Type | Expected publication date |
|---|---|---|
| Cabozantinib for treating advanced hepatocellular carcinoma after prior therapy [ID1243] | Technology appraisal guidance | |
| Cabozantinib for treating advanced neuroendocrine tumours that have progressed after systemic treatment [ID6474] | Technology appraisal guidance | TBC |